143 related articles for article (PubMed ID: 12975722)
1. Switching omeprazole in Sweden and the United States.
Cohen J
Am J Ther; 2003; 10(5):370-6. PubMed ID: 12975722
[TBL] [Abstract][Full Text] [Related]
2. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis.
Shih YC; Prasad M; Luce BR
Clin Ther; 2002 Apr; 24(4):701-16. PubMed ID: 12017413
[TBL] [Abstract][Full Text] [Related]
3. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study.
Nguyen NT; Cook DM; Bero LA
Clin Ther; 2006 Aug; 28(8):1231-1243. PubMed ID: 16982301
[TBL] [Abstract][Full Text] [Related]
4. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
Harris BN; West DS; Johnson J; Hong SH; Stowe CD
J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
[TBL] [Abstract][Full Text] [Related]
5. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
Spencer HM
Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
[No Abstract] [Full Text] [Related]
6. Rx-to-OTC switches: trends and factors underlying success.
Mahecha LA
Nat Rev Drug Discov; 2006 May; 5(5):380-5. PubMed ID: 16604099
[TBL] [Abstract][Full Text] [Related]
7. The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994.
Carlsten A; Wennberg M; Bergendal L
J Clin Pharm Ther; 1996 Dec; 21(6):423-30. PubMed ID: 9201570
[TBL] [Abstract][Full Text] [Related]
8. OTC omeprazole for your heartburn--enormous value-for-money opportunity.
Curtiss FR
J Manag Care Pharm; 2004; 10(5):458-60. PubMed ID: 15369431
[No Abstract] [Full Text] [Related]
9. Real-world Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM.
Kühler TC; Ateka A; Lassoued Z; Routhier FX; Mékary-Sawaya S
Clin Ther; 2024 Mar; 46(3):208-216. PubMed ID: 38278703
[TBL] [Abstract][Full Text] [Related]
10. The effect of generic competition on prescription to over-the-counter switching.
Hollenbeak CS
Pharmacoeconomics; 1999 Dec; 16(6):661-8. PubMed ID: 10724793
[TBL] [Abstract][Full Text] [Related]
11. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
12. Rx-to-OTC switch movement.
Rosenau PV
Med Care Rev; 1994; 51(4):429-66. PubMed ID: 10139533
[No Abstract] [Full Text] [Related]
13. A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches.
Fisher M; Rawal K
Ther Innov Regul Sci; 2023 Sep; 57(5):1074-1080. PubMed ID: 37357243
[TBL] [Abstract][Full Text] [Related]
14. The "prescription-to-OTC switch" movement. Its effects on antifungal vaginitis preparations.
Lipsky MS; Waters T
Arch Fam Med; 1999; 8(4):297-300. PubMed ID: 10418534
[TBL] [Abstract][Full Text] [Related]
15. Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn.
Fendrick AM; Shaw M; Schachtel B; Allgood L; Allgood G; Grender J; Peura D
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):17-21. PubMed ID: 15017628
[TBL] [Abstract][Full Text] [Related]
16. Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development.
Cohen J; Millier A; Karray S; Toumi M
J Med Econ; 2013; 16(6):835-44. PubMed ID: 23597040
[TBL] [Abstract][Full Text] [Related]
17. Why aren't lower, effective, OTC doses available earlier by prescription?
Cohen JS
Ann Pharmacother; 2003 Jan; 37(1):136-42. PubMed ID: 12503949
[TBL] [Abstract][Full Text] [Related]
18. Prescription to over-the-counter switch: a regulatory perspective.
Juhl RP
Clin Ther; 1998; 20 Suppl C():C111-7. PubMed ID: 9915097
[TBL] [Abstract][Full Text] [Related]
19. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
Kalish SC; Bohn RL; Avorn J
Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
[TBL] [Abstract][Full Text] [Related]
20. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]